choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Norvasc

Norvasc Newsletter
  • A Common Blood Pressure Medication May Help Treat Symptoms of ADHD 21 Feb 2025 22:54 GMT

    Amlodipine (Norvasc; Pfizer), a blood pressure medication, was efficacious and well- … like viloxazine (Qelbree; Supernus Pharmaceuticals Inc). Patients may also utilize … a novel ADHD treatment through cross-species analysis, drug-target Mendelian …

  • Study says generic drugs are as effective as branded ones 10 Feb 2025 06:01 GMT

    Medicine, found that a generic version of the high blood pressure drug Norvasc … no related complaints from clinical doctors, and a senior colorectal surgeon … said it will encourage frontline doctors to use a monitoring platform …

  • Amlodipine (Norvasc) dosage 03 Dec 2024 14:14 GMT

    … a brand-name version (Norvasc). Keep reading for … amlodipine, your doctor will discuss your treatment plan with you … what the Food and Drug Administration (FDA) approved it for … doctor or another healthcare professional before taking any medication. The drug

  • 2 Generic Drug Stocks Ready to Surge in 2025 29 Nov 2024 13:39 GMT

    drug for type-2 diabetes, as a first-line treatment … osteoporosis drug Prolia to the FDA and European Medicines Agency … drug Lipitor, Viagra, antidepressant Zoloft, Lyrica, Influvac, and Norvasc … agreement with Lexicon Pharmaceuticals (NASDAQ:LXRX) for …

  • Polypharmacy and Drug Effects on Aβ Fibrillation in Neurodegenerative Diseases 18 Nov 2024 14:11 GMT

    … summary of “Highly prevalent geriatric medications and their effect on β-amyloid … hydrogensulfate (Flomax), levothyroxine, and amlodipine (Norvasc). Drugs exhibited polyphenolic components, which are …

  • Insilico Plans Pivotal Trial for AI-Based IPF Candidate 12 Nov 2024 15:15 GMT

    … calcium), Lovenox® (enoxaparin sodium), Norvasc® (amlodipine), Velcade® (bortezomib), … novel drugs, and revolutionize the treatment landscape … Medical College and the Phase IIa trial’s principal investigator. U.S. trial … March in Nature Biotechnology, a team …

  • ESC 2024: Single-pill hypertension combo delivers positive results 02 Sep 2024 12:08 GMT

    … controlled trial (NCT04518306) investigated a single-pill combination therapy for the initial treatment … the former drug as Micardis, whilst Viatris sells amplodipine as Norvasc, and … . London, UK-based George Medicines is developing this triple combination …

  • USPTO Publishes Drug Patent and Exclusivity Study Report 25 Jun 2024 01:18 GMT

    … conjunction with the Food and Drug Administration (FDA) and in response to … development of innovative medicines and the availability of generic drugs and addresses … ) (e.g., VENTOLIN HFA, AMBIEN, NORVASC, or XARELTO), whereas other products …

  • Viagra maker Viatris misses revenue estimates on weak demand for older drugs 09 May 2024 13:38 GMT

    … dysfunction drug Viagra, anti-anxiety medication Xanax, epilepsy treatment Lyrica and arthritis treatment Celebrex … its over-the-counter (OTC) drugs, active pharmaceutical ingredients (API) and women … .9 million a year ago. Norvasc recorded net sales of $176 …

  • Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast 09 May 2024 18:42 GMT

    … Mistras. Sales of the cholesterol medication Lipitor declined from $417.9 … .9 million, and sales of Norvasc for high blood pressure reached …

Satisfied with the content?

Continue to create your account.